Pharma Industry Fears Innovation Slump Due to Price Cuts
1The government is cutting drug prices to save health insurance funds.
2Pharma firms worry lower profits will hinder new drug development.
3There are concerns that access to innovative treatments may be delayed.
📖 Easy Explanation
🔍 Background
With limited health insurance funds, the government is trying to reduce spending by lowering the prices of medicines.
📌 Key Points
While the government saves money, pharmaceutical companies argue that low prices leave them with insufficient funds for R&D, weakening their ability to create new drugs.
💡 Why It Matters
While lower prices are initially beneficial, there are concerns that breakthrough treatments might not be developed or released in the country in a timely manner.
📚 Glossary
약가정책 (Yakga-jeongchaek)A system where the government determines or manages the prices of medicines.
혁신 신약 (Hyeoksin-sinyak)Drugs that are more effective than existing treatments or use new methods to cure diseases.